Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL cytoplasmic 479, pseudogene (RN7SL479P)
- Target
- RN7SL479P
- Molecular classification
- Other (specifically: pseudogene, noncoding RNA-derived sequence)
01
Overview
RN7SL479P (RNA, 7SL cytoplasmic 479, pseudogene) is a non-functional, sequence-derived pseudogene related to the 7SL RNA gene. The 7SL RNA is a noncoding RNA that constitutes the RNA component of the signal recognition particle (SRP), which is involved in the targeting and translocation of proteins across membranes[1][3]. By contrast, most 7SL pseudogenes, including RN7SL479P, arise from reverse-transcribed 7SL RNA sequences being reinserted into the genome, often as truncated and mutated copies that do not yield a functional product[5][6][7]. These pseudogenes are highly prevalent in the human genome and do not participate in SRP or any known cellular processes. There is no evidence of RN7SL479P being transcribed or having a biological role; it is classified as a genetic fossil rather than a true molecular target[4][6][7].
- Other names
- RN7SL479PRNA, 7SL cytoplasmic 479, pseudogene7SL pseudogene
02
Mechanism of action
None. Since RN7SL479P is a pseudogene and not targeted by any drugs, mechanisms of action are not defined
03
Biological functions
Pseudogenes typically lack biological function due to mutations, truncations, or absence of essential regulatory elementsSome pseudogenes can be transcribed, and rare examples of pseudogene-derived non-coding RNAs have regulatory effects (e.g. acting as competing endogenous RNAs), but there is no direct evidence for RN7SL479P exerting such functions
04
Disease associations
None. There is no evidence linking RN7SL479P to any disease as a causative or contributing factor
05
Safety considerations
None. There are no safety concerns or challenges associated with the pseudogene RN7SL479P
06
Interacting drugs
None. No drugs are known to interact with RN7SL479P, as it is neither a protein nor a functional RNA
07
Biomarkers
None. RN7SL479P is not used as a biomarker for patient selection or monitoring
Beyond the preview
Go deeper on RNA, 7SL cytoplasmic 479, pseudogene (RN7SL479P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 7SL cytoplasmic 479, pseudogene (RN7SL479P).